#PGHL
Pharma industry
CMP: 5200
UPSIDE 30% ( 6-9 months)
FUNDAMENTALS:
market cap 8700
Good ROE 30% and ROCE 40%
Good OPM 25%
Increased holding by DII and FII QOQ
Reduced public holding QOQ
Reduced Shareholders numbers on YOY and QOQ basis ( positive as old shareholders are accumulating share)
TECHNICALS:
Above 50 DMA (not ran up, near 50 DMA)
Above 200 DMA
Near 52 week high (<5% from 52week high)
RSI in comfortable zone(between 30-70)
CONS: Poor sales and Profit growth
Disclaimer: Invested recently because of its good fundamentals and soon it will be technical pick as it will break 52week high; good pharma small cap MNC with proven track record and sound management.
Subscribe To Our Free Newsletter |